AU Stock MarketDetailed Quotes

Argenica Therapeutics Ltd (AGN)

Watchlist
  • 0.300
  • 0.0000.00%
20min DelayMarket Closed Jan 15 16:00 AET
38.54MMarket Cap-5.36P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Argenica Therapeutics Ltd (AGN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2025
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
Total revenue
Cost of revenue
Gross profit
Operating expense
31.77%10.9M
24.82%8.27M
52.24%6.62M
228.24%4.35M
1.33M
Selling and administrative expenses
16.32%2.41M
-2.00%2.07M
20.90%2.11M
121.37%1.75M
--789.66K
-Selling and marketing expense
--175.98K
----
----
----
----
-General and administrative expense
7.83%2.23M
-2.00%2.07M
20.90%2.11M
121.37%1.75M
--789.66K
Research and development costs
35.16%8.13M
39.66%6.02M
72.60%4.31M
499.94%2.5M
--416.05K
Other operating expenses
95.77%354.74K
-10.89%181.2K
89.31%203.35K
-10.49%107.41K
--120K
Operating profit
-31.77%-10.9M
-24.82%-8.27M
-52.24%-6.62M
-228.24%-4.35M
-1.33M
Net non-operating interest income (expenses)
167.19%512.25K
219.81%191.72K
3,464.03%59.95K
824.18%1.68K
182
Non-operating interest income
166.94%512.75K
214.91%192.09K
2,335.98%61K
1,139.60%2.5K
--202
Non-operating interest expense
36.31%503
-64.86%369
27.74%1.05K
4,010.00%822
--20
Other net income (expenses)
23.70%3.21M
48.46%2.6M
575.38%1.75M
-12.49%259.1K
296.08K
Other non-operating income (expenses)
23.70%3.21M
48.46%2.6M
575.38%1.75M
-12.49%259.1K
--296.08K
Income before tax
-30.86%-7.17M
-13.80%-5.48M
-17.71%-4.82M
-297.37%-4.09M
-1.03M
Income tax
0
0
0
0
54
Earnings from equity interest net of tax
Net income
-30.86%-7.17M
-13.80%-5.48M
-17.71%-4.82M
-297.35%-4.09M
-1.03M
Net income continuous operations
-30.86%-7.17M
-13.80%-5.48M
-17.71%-4.82M
-297.35%-4.09M
---1.03M
Noncontrolling interests
Net income attributable to the company
-30.86%-7.17M
-13.80%-5.48M
-17.71%-4.82M
-297.35%-4.09M
-1.03M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-30.86%-7.17M
-13.80%-5.48M
-17.71%-4.82M
-297.35%-4.09M
-1.03M
Diluted earnings per share
-5.66%-0.056
3.64%-0.053
0.00%-0.055
-89.66%-0.055
-0.029
Basic earnings per share
-5.66%-0.056
3.64%-0.053
0.00%-0.055
-89.66%-0.055
-0.029
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2025(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021
Total revenue
Cost of revenue
Gross profit
Operating expense 31.77%10.9M24.82%8.27M52.24%6.62M228.24%4.35M1.33M
Selling and administrative expenses 16.32%2.41M-2.00%2.07M20.90%2.11M121.37%1.75M--789.66K
-Selling and marketing expense --175.98K----------------
-General and administrative expense 7.83%2.23M-2.00%2.07M20.90%2.11M121.37%1.75M--789.66K
Research and development costs 35.16%8.13M39.66%6.02M72.60%4.31M499.94%2.5M--416.05K
Other operating expenses 95.77%354.74K-10.89%181.2K89.31%203.35K-10.49%107.41K--120K
Operating profit -31.77%-10.9M-24.82%-8.27M-52.24%-6.62M-228.24%-4.35M-1.33M
Net non-operating interest income (expenses) 167.19%512.25K219.81%191.72K3,464.03%59.95K824.18%1.68K182
Non-operating interest income 166.94%512.75K214.91%192.09K2,335.98%61K1,139.60%2.5K--202
Non-operating interest expense 36.31%503-64.86%36927.74%1.05K4,010.00%822--20
Other net income (expenses) 23.70%3.21M48.46%2.6M575.38%1.75M-12.49%259.1K296.08K
Other non-operating income (expenses) 23.70%3.21M48.46%2.6M575.38%1.75M-12.49%259.1K--296.08K
Income before tax -30.86%-7.17M-13.80%-5.48M-17.71%-4.82M-297.37%-4.09M-1.03M
Income tax 000054
Earnings from equity interest net of tax
Net income -30.86%-7.17M-13.80%-5.48M-17.71%-4.82M-297.35%-4.09M-1.03M
Net income continuous operations -30.86%-7.17M-13.80%-5.48M-17.71%-4.82M-297.35%-4.09M---1.03M
Noncontrolling interests
Net income attributable to the company -30.86%-7.17M-13.80%-5.48M-17.71%-4.82M-297.35%-4.09M-1.03M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -30.86%-7.17M-13.80%-5.48M-17.71%-4.82M-297.35%-4.09M-1.03M
Diluted earnings per share -5.66%-0.0563.64%-0.0530.00%-0.055-89.66%-0.055-0.029
Basic earnings per share -5.66%-0.0563.64%-0.0530.00%-0.055-89.66%-0.055-0.029
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +5.38%
Sample Name
Sample Code
 +2.09%
Sample Name
Sample Code
 +1.44%
4
Tempus AI
TEM
+1.36%
5
Warner Bros Discovery
WBD
+0.86%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -